Lipodystrophy
Abnormal distribution or loss of fat tissue, which can be genetic or acquired (e.g., from HIV treatment or repeated injections at the same site). Tesamorelin is FDA-approved for HIV-associated lipodystrophy.
Frequently Asked Questions
What is Lipodystrophy?
Abnormal distribution or loss of fat tissue, which can be genetic or acquired (e.g., from HIV treatment or repeated injections at the same site). Tesamorelin is FDA-approved for HIV-associated lipodystrophy.
Why is Lipodystrophy important in peptide research?
Understanding lipodystrophy is important because it represents a health condition where peptide interventions are being actively researched. Knowledge of the underlying pathology helps inform peptide selection and protocol design.
Related Terms
Injection site rotation
The practice of alternating injection locations (abdomen, thigh, upper arm, glute) to prevent lipodystrophy, scar tissue buildup, and localized irritation. Sites should be at least 1 inch apart.
LipolysisThe metabolic process of breaking down stored triglycerides into free fatty acids and glycerol for energy use. Stimulated by growth hormone, GH fragments (AOD-9604), and GLP-1 receptor agonists.